Osaic Holdings
XBI icon

Osaic Holdings’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Osaic Holdings’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.1M Buy
423,662
+293,665
+226% +$39.7M 0.08% 262
2026
Q1 		$16.6M Buy
129,997
+1,957
+2% +$244K 0.02% 648
2025
Q4 		$15.6M Buy
128,040
+24,504
+24% +$2.81M 0.02% 693
2025
Q3 		$9.97M Buy
103,536
+31,054
+43% +$2.8M 0.01% 1006
2025
Q2 		$6.01M Sell
72,482
-36,416
-33% -$2.91M 0.01% 1116
2025
Q1 		$8.83M Buy
108,898
+12,967
+14% +$1.16M 0.02% 743
2024
Q4 		$8.64M Sell
95,931
-29,950
-24% -$2.9M 0.02% 750
2024
Q3 		$12.4M Buy
125,881
+51,123
+68% +$5.02M 0.03% 586
2024
Q2 		$6.93M Sell
74,758
-9,081
-11% -$814K 0.02% 821
2024
Q1 		$7.96M Buy
83,839
+179
+0.2% +$16.6K 0.02% 796
2023
Q4 		$7.47M Sell
83,660
-22,986
-22% -$1.71M 0.01% 958
2023
Q3 		$7.79M Buy
106,646
+7,078
+7% +$565K 0.01% 1003
2023
Q2 		$8.3M Sell
99,568
-10,642
-10% -$890K 0.01% 863
2023
Q1 		$8.4M Sell
110,210
-12,183
-10% -$1.01M 0.02% 846
2022
Q4 		$10.2M Buy
122,393
+6,773
+6% +$548K 0.02% 731
2022
Q3 		$9.17M Buy
115,620
+8,002
+7% +$675K 0.02% 701
2022
Q2 		$8.02M Sell
107,618
-47,239
-31% -$3.55M 0.02% 780
2022
Q1 		$13.3M Buy
154,857
+57,850
+60% +$5.34M 0.03% 607
2021
Q4 		$10.9M Sell
97,007
-232
-0.2% -$28K 0.02% 703
2021
Q3 		$12.2M Sell
97,239
-17,462
-15% -$2.25M 0.03% 585
2021
Q2 		$15.5M Sell
114,701
-1,470
-1% -$193K 0.03% 469
2021
Q1 		$15.8M Buy
116,171
+9,966
+9% +$1.49M 0.04% 420
2020
Q4 		$15M Buy
106,205
+15,260
+17% +$1.95M 0.04% 398
2020
Q3 		$10.1M Sell
90,945
-10,909
-11% -$1.22M 0.03% 463
2020
Q2 		$11.4M Buy
101,854
+13,697
+16% +$1.35M 0.04% 398
2020
Q1 		$5.72M Buy
+88,157
New +$7.81M 0.02% 549

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Osaic Holdings's XBI Position: Q2 2026 in Review

Osaic Holdings increased its State Street SPDR S&P Biotech ETF (XBI) stake by 226% in Q2 2026, buying an estimated $39.7M and bringing the position to 423,662 shares worth $67.1M. The position accounts for 0.08% of the portfolio, ranked #262.

Osaic Holdings first reported a position in XBI in Q1 2020 and has held it in 26 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Osaic Holdings held 423,662 shares of State Street SPDR S&P Biotech ETF worth $67.1M as of Q2 2026.
  • Osaic Holdings bought 293,665 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $39.7M.
  • State Street SPDR S&P Biotech ETF made up 0.08% of Osaic Holdings's portfolio in Q2 2026, its #262 holding.
  • Osaic Holdings first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 26 quarters since.
  • 932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.